Lv1
6 积分 2026-03-01 加入
Tissue biomarkers of immune checkpoint inhibitor therapy
3个月前
已完结
Combination cancer immunotherapies: Emerging treatment strategies adapted to the tumor microenvironment
3个月前
已完结
Tumor‐Selective Nano‐Dispatcher Enforced Cancer Immunotherapeutic Effects via Regulating Lactate Metabolism and Activating Toll‐Like Receptors
3个月前
已完结
Targeting lactate metabolism in the tumor microenvironment: Immunomodulation and prospects for antitumor therapy
3个月前
已完结
Lactylation in tumor microenvironment and immunotherapy resistance: New mechanisms and challenges
3个月前
已完结
Nanodrug regulates lactic acid metabolism to reprogram the immunosuppressive tumor microenvironment for enhanced cancer immunotherapy
3个月前
已完结
Design and Optimization of Liposomal Diclofenac Sodium Formulations Using Box–Behnken Experimental Design for Controlled Drug Release
4个月前
已关闭
Erythrocyte–antibody conjugates to overcome immunotherapy resistance
4个月前
已完结
Eythrocyte–anti-PD1 conjugates in persons with advanced solid tumors resistant to anti-PD1/PDL1: preclinical characterization and results of a phase 1 trial
4个月前
已完结
皖公网安备34019202002308
